| 271.11 8.74 (3.33%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 321.08 | 1-year : | 375.02 |
| Resists | First : | 274.89 | Second : | 321.08 |
| Pivot price | 259.94 |
|||
| Supports | First : | 256.72 | Second : | 245.49 |
| MAs | MA(5) : | 263.35 |
MA(20) : | 260.51 |
| MA(100) : | 241.56 |
MA(250) : | 219.25 |
|
| MACD | MACD : | 3.1 |
Signal : | 2.8 |
| %K %D | K(14,3) : | 62.1 |
D(3) : | 50.4 |
| RSI | RSI(14): 66.7 |
|||
| 52-week | High : | 274.89 | Low : | 170.34 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ JNJ ] has closed Bollinger Bands are 14% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 272.06 - 273.07 | 273.07 - 273.88 |
| Low: | 262.97 - 264.24 | 264.24 - 265.27 |
| Close: | 269.19 - 271.16 | 271.16 - 272.76 |
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Tue, 18 Aug 2026
Kansas man convicted of killing Johnson County social worker found dead in prison cell - KMBC
Tue, 18 Aug 2026
Ben Johnson: 'I feel really good about the path we are on' | Press Conference - Chicago Bears
Tue, 18 Aug 2026
Michael William "Mike" Johnson Obituary Aug 18, 2026 - Freeman Family Funeral Homes
Tue, 18 Aug 2026
Anti-socialism push can flip battlegrounds, Republican leader bets as party fights to hold House - Fox News
Tue, 18 Aug 2026
Ben Johnson shares significant update on Bears left tackle competition - Bears Wire
Tue, 18 Aug 2026
Editorial: Brandon Johnson does the right thing on pensions - Chicago Tribune
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - General
|
|
| Shares Out | 2,410 (M) |
| Shares Float | 2,400 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 76.9 (%) |
| Shares Short | 27,430 (K) |
| Shares Short P.Month | 26,690 (K) |
| EPS | 8.63 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 35.27 |
| Profit Margin | 21.4 % |
| Operating Margin | 29.1 % |
| Return on Assets (ttm) | 8.6 % |
| Return on Equity (ttm) | 25.7 % |
| Qtrly Rev. Growth | 6.5 % |
| Gross Profit (p.s.) | 27.68 |
| Sales Per Share | 40.63 |
| EBITDA (p.s.) | 14.46 |
| Qtrly Earnings Growth | -0.9 % |
| Operating Cash Flow | 27,610 (M) |
| Levered Free Cash Flow | 16,890 (M) |
| PE Ratio | 31.41 |
| PEG Ratio | 4.2 |
| Price to Book value | 7.68 |
| Price to Sales | 6.67 |
| Price to Cash Flow | 23.66 |
| Dividend | 1.34 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|